Swift Generic product development (QBD) of solids, liquids and injections for regulated and emerging markets

Product development & technical support for 505 (b)2 products, osmotic drug delivery system, pellets, nanotechnology & mini tablets

Hands on experience on difficult to develop formulations and Para IV product development

Expertise in handling highly unstable molecules (impurities, polymorphism, heat & moisture sensitive) & product development of modified release dosage forms

Breaking the technical barriers in BE studies for BCS class IV & highly variable molecules

Smooth exhibit batch execution and regulatory filings

Support for the post regulatory filing queries

Finished product dossier readiness as per the customer requirement